简体中文English

TERC gene amplification probe kit
Wholesale Price(RMB):

30006000330066003300660036007200

Product Code:R-0501104Ⅰ-01/R-0501104Ⅰ-02/R-0501104Ⅱ-01/R-0501104Ⅱ-02/R-0501104Ⅲ-01/R-0501104Ⅲ-02/R-0501104Ⅳ-01/R-0501104Ⅳ-02
Probe name:GSP TERC / CSP 3
Product Code:Type I (direct FISH method)/Type II (biotin-labeled indirect FISH method)/Type III (digoxigenin-labeled indirect FISH method)/Type IV (TSA-FISH method)
Registration Number:
Clinical Value

Cervical cancer


Patients with precancerous lesions with TERC gene amplification (CIN, or ASCUS, LSIL/HSIL) are significantly more likely to develop cervical cancer (more than 80%);

TERC gene status aids in pathologic grading and guides the choice of treatment regimen, and may prevent overtreatment of patients with precancerous lesions.


Chronic lymphocytic leukemia (CLL)


A tiny 1-2 Mb amplified region on 3q26 can be detected.